Søgning på udtrykket 'covid-19' giver 80 resultater


Dokumenter [8] Sider [2] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [8]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.

Invitation til møde den 20. maj 2022

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sider [2]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2023v26), Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende cyst…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Journal of Infectious Diseases
2.03.2024
Abstract . Objective . To evaluate the impact of hepatitis C virus (HCV) infection and treatment status on COVID-19-related hospitalizations in Georgia.Methods . We analyzed 2020-2021 Georgian health-registry data for COVID-19-positive individuals and categorized by HCV infection and treatment status. Logistic regression was used to assess the strengths of the associations.Results . Treated HCV individuals had lower odds of COVID-19-related hospitalization compared to anti-HCV-negatives, while untreated HCV…
Journal of Infectious Diseases
2.03.2024
…onavirus 2 (SARS-CoV-2) can lead to severe disease with increased morbidity and mortality among certain risk groups. The presence of autoantibodies against type I interferons (aIFN-Abs) is one mechanism that contributes to severe coronavirus disease 2019 (COVID-19).Methods . This study aimed to investigate the presence of aIFN-Abs in relation to the soluble proteome, circulating immune cell numbers, and cellular phenotypes, as well as development of adaptive immunity.Results . aIFN-Abs were more prevalent i…
BMC Infectious Diseases
2.03.2024
. Abstract. . Background. The clinical manifestations of COVID-19 range from asymptomatic, mild to moderate, severe, and critical disease. Host genetic variants were recognized to affect the disease severity. However, the genetic landscape differs among various populations. Therefore, we explored the variants associated with COVID-19 severity in the Guangdong population. . . . …
BMC Infectious Diseases
2.03.2024
… Abstract. . Objectives/Hypothesis. To assess the efficacy of 0.23% povidone-iodine (PVP-I) nasal rinses and mouth washes on detectability of the coronavirus disease 2019 (COVID-19) virus and cycle threshold (Ct) values in nasopharyngeal swabs. . . . Study design. This was an open-label, prospective, randomized, placebo-controlled clinical t…
Critical Care Explorations
2.03.2024
… ICUs experience persistent critical illness (PerCI), a phenomenon in which features of the ICU course more consistently predict mortality than the initial indication for admission. We aimed to describe PerCI among patients with critical illness caused by COVID-19, and these patients’ short- and long-term outcomes. DESIGN: . Multicenter retrospective cohort study. SETTING: . Australian and New Zealand Intensive Care Society Adult Patient Database of 114 Australian ICUs between January 1, 2020, and March…
Critical Care Explorations
2.03.2024
… up the use of point-of-care ultrasound (POCUS) in critically ill patients. DESIGN: . Retrospective analysis of medical records and EASy examination images. SETTING: . Tertiary care academic hospital. PATIENTS: . A total of 14 adults (> 18 yr old) with COVID-19-associated respiratory failure under the care of Albany Medical Center’s surge response team from April 6–17, 2020 who received at least one EASy examination. INTERVENTIONS: . Residents (previously novice sonographers) were trained in EASy ex…
Science Advances
2.03.2024
Science Advances, Volume 10, Issue 9, March 2024.
American Journal of Respiratory and Critical Care Medicine
1.03.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 5, Page 573-583, March 1, 2024.
Proceedings of the National Academy of Sciences: Immunology and Inflammation
1.03.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 10, March 2024.
PLoS One Infectious Diseases
1.03.2024
by Aneliana da Silva Prado, Sabrina Baldofski, Elisabeth Kohls, Christine Rummel-Kluge . Background The COVID-19 pandemic affected university students’ mental health worldwide. International students were presenting high levels of stress, anxiety, and depressive symptoms before the pandemic. This study aimed to investigate (i) differences between various timepoints of the COVID-19 pandemic (2020, 2021, and 2022) in mental health outcomes and social and emotional aspects in domestic and international stud…
Clinical Microbiology and Infection
29.02.2024
We have read the letter by Rus and Kooij regarding our study of COVID-19 related mortality among selective serotonin reuptake inhibitor (SSRI) -users with great interest and we thank Rus and Kooij for the interest in our study.1,2 The main claim by Rus and Kooij is that psychiatric comorbidity and lifestyle factor could contribute to residual confounding in our study.2 These limitations are already acknowledged and discussed in our article, but we appreciate the opportunity to explain our considerations in …
New England Journal of Medicine
29.02.2024
New England Journal of Medicine, Volume 390, Issue 9, Page 806-818, February 2024.
New England Journal of Medicine
29.02.2024
New England Journal of Medicine, Volume 390, Issue 9, Page 863-865, February 2024.
PLoS One Infectious Diseases
29.02.2024
by Masashi Shibata, Yuki Otsuka, Hideharu Hagiya, Toshihiro Koyama, Hideyuki Kashiwagi, Fumio Otsuka . Background In the global aging, the coronavirus disease 2019 (COVID-19) pandemic may have affected the place of death (PoD) in Japan, where hospital deaths have dominated for decades. We analyzed the PoD trends before and during the COVID-19 pandemic in Japan. Methods This nationwide observational study used vital statistics based on death certificates from Japan between 1951 and 2021. The proportion of …
PLoS One Infectious Diseases
29.02.2024
…ncis Diji, Victoria Bam . Background Pregnant women are among the most vulnerable and suffer the most during pandemics, according to earlier studies. Pregnant women had to seek healthcare for both themselves and their unborn child(ren) in the wake of the COVID-19 pandemic, which was unprecedented. Pregnant women’s psychosocial experiences during pandemics are crucial since they both directly and indirectly affect the course of pregnancy and childbirth. The study therefore sought to explore the psychosoci…
Critical Care Medicine
28.02.2024
Objectives: . To evaluate the impact of intubation timing, guided by severity criteria, on mortality in critically ill COVID-19 patients, amidst existing uncertainties regarding optimal intubation practices. Design: . Prospective, multicenter, observational study conducted from February 1, 2020, to November 1, 2022. Setting: . Ten academic institutions in the United States and Europe. Patients: . Adults (≥ 18 yr old) confirmed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection…
International Journal of Infectious Diseases
28.02.2024
Although the World Health Organization (WHO) ended the global emergency status for COVID-19 on May 5th 2023, reports on long-lasting symptoms after COVID-19 have been emerging. Over 200 long-lasting symptoms affecting various organ systems have been documented in more than 65 million individuals worldwide [1]. These symptoms are referred to as ‘’long-COVID’’, ‘’post COVID-19 condition’’ (PCC) and ‘’post-acute sequalae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)’’.…
BMJ Open
28.02.2024
. Objectives. To investigate the impact of the COVID-19 pandemic as well as concomitant COVID-19 itself on stroke care, focusing on middle cerebral artery (MCA) territory infarctions. . Design. Registry-based study. . Setting. We used the National Inpatient Sample (NIS) database, which covers a wide range of hospitals within the USA. . Participants. The NIS was queried for patients with MCA strokes between 2016 and 2020. In total, 35 231 patients were included. . Outcome measures. Outcome measures were …
Lancet Respiratory Medicine
28.02.2024
The identified risk factors for CAPA could eventually be addressed with targeted antifungal prophylaxis in patients with severe COVID-19.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Statens Serum Institut
23.02.2024
Verdens største studie af covid-19 vaccinernes sikkerhed bekræfter, at alvorlige bivirkninger efter vaccination sjældne.
Eurosurveillance latest updates
23.02.2024
…ce and vaccine coverage data, even if these data cannot be linked. In Germany, where notification data, laboratory testing data, and vaccine coverage data cannot be linked due to strict data protection requirements, the screening method was used to assess COVID-19 VE continuously between July 2021 and March 2023. During this period, when Delta and Omicron variants circulated, VE estimates were produced in real-time for different age groups and clinical outcomes. Here we describe the country’s overall posi…
Eurosurveillance latest updates
23.02.2024
. Background. Wastewater surveillance has expanded globally as a means to monitor spread of infectious diseases. An inherent challenge is substantial noise and bias in wastewater data because of the sampling and quantification process, limiting the applicability of wastewater surveillance as a monitoring tool. . . Aim. To present an analytical framework for capturing the growth trend of circulating infections from wastewater data and conducting scenario analyses to guide policy decisions. . . Methods.…
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Statens Serum Institut
22.02.2024
I den brede danske befolkning blev der diagnosticeret flere neurologiske lidelser efter smitte med covid-19. Det viser en ny stor undersøgelse fra Statens Serum Institut, hvor der indgik knap 1,8 mio smittede danskere.
Eurosurveillance latest updates
16.02.2024
Many vaccine effectiveness (VE) analyses of severe disease outcomes such as hospitalisation and death include ‘false’ cases that are not actually caused by the infection or disease under study. While the inclusion of such false cases inflate outcome rates in both vaccinated and unvaccinated populations, it is less obvious how they affect estimates of VE. Illustrating the main points through simple examples, this article shows how VE is underestimated when false cases are included as outcomes. Depending …
ECDC COVID-19 updates
13.02.2024
This protocol presents a common updated methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating European Union and European Economic Area (EU/EEA) countries.
Statens Serum Institut
8.02.2024
Særligt på sociale medier har der gennem længere tid floreret en myte om, at de første små partier af covid-19 vaccinen ikke havde samme kvalitet som de senere større partier, og at de derfor førte til langt flere bivirkninger. Denne myte punkteres nu i en ny stor undersøgelse fra Statens Serum Institut.
ECDC COVID-19 updates
6.02.2024
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
ECDC COVID-19 updates
2.02.2024
This downloadable data file contains information on COVID-19 vaccination in the EU/EEA since September 2023.
Medscape Infectious Diseases
1.02.2024
Amid the current winter wave surge of respiratory virus cases, how challenging is it for physician's to distinguish between, diagnose, and treat COVID-19 vs RSV and influenza? . Medscape Medical News
ECDC COVID-19 updates
26.01.2024
This report presents an interim description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and January 2024.
Morbidity and Mortality Weekly Report (MMWR)
26.01.2024
This report describes a review of immunosuppressed patients with nonsevere COVID-19 who were not treated with an antiviral drug.
Medscape Infectious Diseases
24.01.2024
Infection rates are declining overall, but continuing vigilance is crucial, said WHO. . Medscape Medical News
Statens Serum Institut
23.01.2024
Personer over 35 år, kvinder, overvægtige og mennesker med lidelser som depression og astma var særligt udsatte for senfølger efter covid-19 infektion tidligt i pandemien, konkluderer ny undersøgelse.
Eurosurveillance latest updates
19.01.2024
. Background. Contact tracing was one of the central non-pharmaceutical interventions implemented worldwide to control the spread of SARS-CoV-2, but its effectiveness depends on its ability to detect contacts. . . Aim. Evaluate the proportion of secondary infections captured by the contact tracing system in Geneva. . . Methods. We analysed 166,892 concomitant infections occurring at the same given address from June 2020 until February 2022 using an extensive operational database of SARS-CoV-2 tests in…
Eurosurveillance latest updates
19.01.2024
We conducted a multicentre hospital-based test-negative case–control study to measure the effectiveness of adapted bivalent COVID-19 mRNA vaccines against PCR-confirmed SARS-CoV-2 infection during the Omicron XBB lineage-predominant period in patients aged ≥ 60 years with severe acute respiratory infection from five countries in Europe. Bivalent vaccines provided short-term additional protection compared with those vaccinated > 6 months before the campaign: from 80% (95% CI: 50 to 94) for 14…

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.12.2
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.725 s

Cookies og privatliv